Does Biogen’s Recent Win Make It a Must-Buy Stock?

Shares of Biogen (BIIB -0.28%) soared late last month after the company again received positive results around one of its Alzheimer’s treatments. It wasn’t Aduhelm this time, but a new promising trea… Read full article

Leave a Reply

Your email address will not be published.